Screener
LeMaitre Vascular LMAT Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333762
| Line item | Three months ended / June 30, 2026 | Three months ended / June 30, 2025 | Six months ended / June 30, 2026 | Six months ended / June 30, 2025 |
|---|---|---|---|---|
| Sales and marketing | 14,408 | 14,895 | 28,923 | 29,107 |
| General and administrative | 11,110 | 10,396 | 23,156 | 20,883 |
| Research and development | 4,847 | 3,541 | 8,907 | 7,636 |
| Total operating expenses | 30,365 | 28,832 | 60,986 | 57,626 |
| Income from operations | 20,399 | 16,142 | 38,174 | 28,768 |
| Other income (expense): | ||||
| Investment income | 3,386 | 2,980 | 6,710 | 5,883 |
| Interest expense | (1,302) | (1,299) | (2,602) | (2,589) |
Item 1. Financial Statements
FAQ
- What is LeMaitre Vascular's total operating expenses?
- LeMaitre Vascular (LMAT) reported total operating expenses of $30.37M in Q2 2026.
- How has LeMaitre Vascular's total operating expenses changed year-over-year?
- LeMaitre Vascular's total operating expenses increased by 5.3% year-over-year, from $28.83M to $30.37M.
- What is the long-term trend for LeMaitre Vascular's total operating expenses?
- Over 4 years (2021 to 2025), LeMaitre Vascular's total operating expenses has grown at a 14.2% compound annual growth rate (CAGR), from $64.96M to $110.63M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about LeMaitre Vascular's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude